Hemobag logo

 Home

 Background

 Clinical uses

 Benefits
 Ultrafiltration

 How to purchase

 Resources

Methodology  View the video  FAQs  Contact Us 

Resources

Suggest a resource or link

Index

Hemobag information

The Hemobag® is the only autotransfusion product on the market salvaging and concentrating all autologous whole blood fractions and constituents for Cardiac, Thoracic and Vascular Surgery, helping to avoid unnecessary allogeneic blood product use. This technique offers perfusionists a new role in optimizing hemostasis and homeostasis hours after the termination of surgery. Saving More Blood, Reducing Costs, and Improving Patient Outcomes!

Cell Washer ATS Waste Calculator & Cost Estimator

 ** Recognition for Global Blood Resources

Feature article on the Hemobag®

Flyer (longer version:):PDF Hemobag® Autologous Whole Blood Salvage Device for Surgery

Flyer (short version): PDF The Hemobag® (what cell washers discard that the Hemobag® retains)

Earlier Hemobag® brochure

NetCap E-newsletter  - PDF Fall edition featuring the Hemobag®

PDF Doctors take recycling to heart. Hemobag recycles patient's blood during surgery (Statesman Journal, Salem, Oregon, 9 Mar. 2007)

Riley JB, Samolyk KA, Lich BV, Moskowitz B, Shander A.PDF Results from the Perfusion.com cardiac surgery hematocrit trend survey: observations and evidence-based recommendations. January 2006.

 
 PAPERS

  POSTERS & PRESENTATIONS  

Powerpoint Powerpoint Posters: Once downloaded, if required, select Edit Slide from EDIT menu,  then VIEW menu - Zoom - 200% 

  • Powerpoint Improved coagulation after cardiopulmonary bypass using the Hemobag® (Promedica cardiothoracic surgeons meeting, Beverly Hills, Oct. 5-7, 2006) Select Open, then Edit Slide from EDIT menu.

    | TOP |

    Blood conservation & management 

    Articles/Reports/Resources

    NewAnemia can help body heal, study finds (11 Aug. 2008)

    NewBloodless surgery (video)

    NewBloodless surgery clears way for better care (14 July 2008)

    Fewer transfusions lowers costs, helps patient (5 May 2008)

    Blood myths (NSW Govt., Australia)

    • Myth 1: "Blood, it's safer than it's ever been"
    • Myth 2: "A blood transfusion will get my patient home sooner"
    • Myth 3: "Blood transfusions improve healing"
    • Myth 4: "Autologous blood (pre-donated) is risk-free"
    • Myth 5: "Blood, it's free anyway"

    TrasylolR in the news

    Blood substitutes

    Results of blood substitute trial show no survival advantage to trauma patients (25 Oct. 2007)

    Biopure seeks compassionate use protocol for treatment of acute anemia (24 Aug. 2007)

    Northfield Laboratories turns into a zombie (Polyheme) (23 May 2007)

    How artificial blood works (howstuffworks.com)

    Blood Management

    AABB, ARC, ABC: Joint Statement Before the Advisory Committee on Blood Safety and Availability, May 30, 2008: Clinical Significance of Red Cell Age in Transfusions

    PDFOlder Red Cells - BEST Collaborative view of the evidence (presentation to U.S. Dept of HHS Advisory Committee on Blood Safety & Availability, 30 May 2008 - 55 slides)

    PDF BEST Collaborative responds to recent studies purporting to show that transfusion of older red blood cells leads to greater risk (press release, 27 May 2008)

    Joint Commission initiates Phase II of Blood Management Performance Measures Project

    Restrictive blood transfusion does not worsen clinical outcome (online CME/CE activity)

    Isbister J. PDF From transfusion to patient blood management (72-slide presentation)

    Treating patients like Jehovah's Witnesses could save lives: experts say (28 May 2007)

    Taking a harder line on blood transfusions (CAP Today, May 2007)

    FDA strengthens safety information for erythropoiesis-stimulating agents (9 Mar. 2007)

    Predictor of mortality In cardiac patients found by researchers

    Blood transfusions should be used in moderation for acute coronary syndrome (Duke University study)

    Intra-operative cell salvage (online CE courses from UK)

    Doctors question whether all blood transfusions are effective and necessary. Br Med J  2005 Mar12;330:558.

     SABM Reference Library

    Transfusion Alert: Use of Autologous Blood (National Heart, Lung, and Blood Institute)

    Transfusion brings experts' blood to a boil (The Australian, 16 June 2007)

    US heart patients receive more transfusions than international patients (Medical News Today, 18 Nov. 2005)

    NewAnemia Management and Blood Conservation in the Hospital Setting (CME/CE)

    Agarwal MB. The ideal transfusion trigger in critically ill patients. Indian J Crit Care Med [serial online] 2007 [cited 2008 Jan 13 ;11:173-5.

    Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006 May-Jun;21(3):320-6.

    Barone J, et al. Blood doping in the surgical intensive care unit: evidence-based surgical rebuttal. Surgery. 2007 Jan;141(1):7-8

    Beckmann SR, Carlile D, Bissinger RC, Burrell M, Winkler T, Shely WW. Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass. J Extra Corpor Technol 2007 Jun;39(2):103-8.

    Bennett J, Haynes S, Torella F, Grainger H, McCollum C. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion 2006 Jul;46(7):1097-103.

    Carless P, Henry D, Moxey A, O'connell D, Brown T, Fergusson D. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2006 Oct 18;4:CD001888.

    Ciurea SO, Hoffman R. Cytokines for the treatment of thrombocytopenia. Semin Hematol 2007 Jul; 44(3):166-82.

    Donat R Spahn DR, Marcucci C. Blood management in intensive care medicine: CRIT and ABC – what can we learn? Crit Care. 2004; 8(2): 89–90.

    Feltracco P, Michieletto E, Barbieri S, Serra E, Rizzi S, Salvaterra F, Cillo U, Ori C. Microbiologic contamination of intraoperative blood salvaged during liver transplantation. Transplant Proc. 2007 Jul-Aug;39(6):1889-91.

    NewFergusson DA, McIntyre L. The future of clinical trials evaluating blood substitutes. JAMA 2008 May 21;299(19):2324-6. Epub 2008 Apr 28.

    Fliser D, Haller H. Erythropoietin and treatment of non-anemic conditions-cardiovascular protection. Semin Hematol 2007 Jul;44(3):212-7.

    Freedman J, Luke K, Monga N, Lincoln S, Koen R, Escobar M, Chiavetta J. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONTraC). Transfus Apher Sci 2005 Nov;33(3):343-9.

    NewGerber DR. Transfusion of packed red blood cells in patients with ischemic heart disease. Crit Care Med. 2008 Apr;36(4):1068-74

    Gould S, Cimino MJ, Gerber DR. Packed red blood cell transfusion in the intensive care unit: limitations and consequences. Am J Crit Care. 2007 Jan;16(1):39-48. 

    Karger R, Kretschmer V. Modern concepts of autologous haemotherapy. Transfus Apheresis Sci 2005 Apr;32(2):185-96.

    Kristeller JL, Stahl RF, Roslund BP, Roke-Thomas M. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. Pharmacotherapy. 2007 Jul;27(7):988-94.

    Lee LY, DeBois WJ, Krieger KH, Isom OW. Transfusion therapy and blood conservation. In: Cohn LH, Edmunds LH Jr, eds. Cardiac surgery in the adult. New York: McGraw-Hill, 2003:389-400. (Table of Contents)

    Maglish Ehrman BL, Moore HA. Blood conservation strategies in cardiovascular surgery. Dimens Crit Care Nurs 2004 Nov/Dec; 23(6): 244-52.

    Managing blood loss (Anemia Institute)

    Moonen AF, Knoors NT, van Os JJ, Verburg AD, Pilot P. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion 2007 Mar;47(3):379-84.

    Munoz M, Leal-Noval R, Garcia-Erce JA. Intravenous iron in cardiac surgery. Semin Hematol 2006 Oct;43(4 Suppl 6):S39-42.

    Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill (review). Chest 2005 Jan; 127(1):295-307.

    Scott BH, Seifert FC, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth. 2008 Jan-Jun;11(1):15-9.

    Shander A, Goodnough LT. Objectives and limitations of bloodless medical care. Curr Opin Hematol 2006 Nov;13(6):462-70.

    Shander A, Moskowitz D, Rijhwani TS. The safety and efficacy of "bloodless" cardiac surgery. Semin Cardiothorac Vasc Anesth 2005 Mar;9(1):53-63.

    Shehata N, Wilson K, Mazer CD, Tomlinson G, Streiner D, Hebert P, Naglie G. The proportion of variation in perioperative transfusion decisions in Canada attributable to the hospital. Can J Anaesth. 2007 Nov;54(11):902-7.

    Shehata N, Naglie G, Alghamdi AA, Callum J, Mazer CD, Hebert P, Streiner D, Wilson K. Risk factors for red cell transfusion in adults undergoing coronary artery bypass surgery: a systematic review. Vox Sang 2007 Jul;93(1):1-11.

    Stowell CP. What happened to blood substitutes? Transfus Clin Biol 2005 Nov 30; [Epub ahead of print]

    NewTinmouth AT, McIntyre LA, Fowler RA. Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients. CMAJ 2008;178 49-57.

    Watson N, Taylor C. Allogeneic blood transfusion - the alternatives. Hospital Pharmacist 2000 May; 7(5): 118-123.

    Whitson BA, Huddleston SJ, Savik K, Shumway SJ. Bloodless cardiac surgery is associated with decreased morbidity and mortality. J Card Surg 2007 Sep-Oct;22(5):373-8.

    Wiedermann CJ. Hydroxyethyl starch--can the safety problems be ignored? Wien Klin Wochenschr. 2004 Sep 30;116(17-18):583-94

    Zilberberg MD, Shorr AF. Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. BMC Health Services Research 2007;7:138. (31 Aug. 2007)

    The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfus Med Rev 2005 Jan; 19(1):66-78.

    Changes in blood supplies, regulations, and transfusion practice. Clinicians need to prepare for shortages now. (editorial) (Br Med J 2005 Feb 5;330:268-9)

    Associations, Organizations, etc.

    | TOP |

    Conferences

    Education and guidelines

    PDFThe Hemobag® brochure  

    AABB: PDF2005 nationwide blood collection & utilization survey

    Albumin guidelines (Perfusion.ca)

    CME/CE: Anemia Management and Blood Conservation in the Hospital Setting

    Bloody Easy Online Course - Sunnybrook & Women's College HSC, Toronto, Canada (targetted to nurses, physicians, technologists)

    Canadian Blood Services: Clinical Guide to Transfusion (edited by Gwen Clarke and Morris Blajchman)

    Clinical Use of Blood (WHO, 2004)Learn Intra-Operative Cell Salvage (online course from the UK National Blood Service)

    Transfusion Pocket Guides (Australian Red Cross Blood Service)

    Haljamäe H. Crystalloids versus colloids: the controversy. In: Transfusion Medicine and Alternatives to Blood Transfusion, 2000 Edition, Network for Advancement of Transfusion Alternatives (NATA).

    NewOptimizing Blood Management in Cardiovascular Surgery: Why & How (HemostasisCME.Org)

    Restrictive blood transfusion does not worsen clinical outcome (online CME/CE activity)

    PDF Spahn DR. Transfusion associated with improved outcomes - where is the evidence?

    TraQ: Transfusion practice guidelines

    UK blood transfusion and tissue transplantation guidelines

    | TOP |

    Journal articles (Miscellaneous)

    • Vanderlinde ES, Joanna M Heal JM, Blumberg N. Autologous transfusion (review). Br Med J 2002 Mar 30;324:772-5.

    Perfusion sites

    Regulation

    | TOP |

     Related professional sites

    Ultrafiltration 

    Related miscellaneous sites

    | TOP |

    • The Hemobag® - An Improved Way to Salvage Autologous Whole Blood in Surgery

    | Methodology | View the video | FAQs | Contact Us |